PCS
ABVX

Personal CFO Solutions’s Abivax ABVX Stock Holding History

Personal CFO Solutions’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Buy
3,027
+288
+11% +$34.1K 0.05% 336
2025
Q4 		$369K Buy
+2,739
New +$299K 0.06% 301

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Personal CFO Solutions's ABVX Position: Q1 2026 in Review

Personal CFO Solutions increased its Abivax (ABVX) stake by 11% in Q1 2026, buying an estimated $34.1K and bringing the position to 3,027 shares worth $337K. The position accounts for 0.05% of the portfolio, ranked #336.

Personal CFO Solutions first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $369K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Personal CFO Solutions held 3,027 shares of Abivax worth $337K as of Q1 2026.
  • Personal CFO Solutions bought 288 Abivax shares in Q1 2026, an estimated $34.1K.
  • Abivax made up 0.05% of Personal CFO Solutions's portfolio in Q1 2026, its #336 holding.
  • Personal CFO Solutions first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Personal CFO Solutions's Abivax position peaked at $369K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.